LIFE EXPECTANCY IN PATIENTS WITH STAGE III A NON-SMALL CELL LUNG CANCER (NSCLC) TREATED WITH NEOADJUVANT CHEMORADIOTHERAPY (NCRT), NEOADJUVANT CHEMOTHERAPY (NCT), NEOADJUVANT CHEMOTHERAPY + ADJUVANT RADIATION THERAPY (NCT + ADJUVANT RT)

Katerina Maliarchuk; Andrey Ganul; Bogdan Borisyuk; Leonid Bororov; Anatoly Shevchenko; Vladimir Sovenko; Lubov Kutsenko

doi:10.5114/hpc.2022.121417

eISSN: 2354-0265
ISSN: 2353-6942

Health Problems of Civilization Physical activity: diseases and issues recognized by the WHO

Bieżący numer Archiwum Online first O czasopiśmie Rada naukowa Recenzenci Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Standardy etyczne i procedury

Panel Redakcyjny

Zgłaszanie i recenzowanie prac online

Wyszukiwanie

Zasady redakcyjne

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

4/2022
vol. 16

Poleć ten artykuł:

Wyślij znajomemu

Skopiuj link:

Udostępnij:

CHOROBY I PROBLEMY WYRÓŻNIONE PRZEZ WHO I FAO

Artykuł oryginalny

PRZEWIDYWANA DŁUGOŚĆ ŻYCIA U PACJENTÓW Z NIEDROBNOKOMÓRKOWYM RAKIEM PŁUCA W STADIUM III A (NSCLC) PODDANYCH NEOADJUWANTOWEJ CHEMIORADIOTERAPII (NCRT), NEOADJUWANTOWEJ CHEMIOTERAPII (NCT), NEOADJUWANTOWEJ CHEMIOTERAPII + ADJUWANTOWEJ RADIOTERAPII (NCT + ADJUWANTOWA RT)

Katerina Maliarchuk

¹

,

Andrey Ganul

²

,

Bogdan Borisyuk

²

,

Leonid Bororov

²

,

Anatoly Shevchenko

²

,

Vladimir Sovenko

²

,

Lubov Kutsenko

³

Department of Oncology, the Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine

Department of Chest and Mediastinal, National Cancer Institute, Kyiv, Ukraine

Department of Statistics, National Cancer Institute, Kyiv, Ukraine

Health Prob Civil. 2022; 16(4): 302-311

DOI: https://doi.org/10.5114/hpc.2022.121417

Data publikacji online: 2022/12/30

Plik artykułu:

- HPC_4 2022_Art 3_Maliarchuk.pdf [0.96 MB]

Pobierz cytowanie

EndNote

Papers, Reference Manager, RefWorks, Zotero

AMA

Maliarchuk K, Ganul A, Borisyuk B, et al. LIFE EXPECTANCY IN PATIENTS WITH STAGE III A NON-SMALL CELL LUNG CANCER (NSCLC) TREATED WITH NEOADJUVANT CHEMORADIOTHERAPY (NCRT), NEOADJUVANT CHEMOTHERAPY (NCT), NEOADJUVANT CHEMOTHERAPY + ADJUVANT RADIATION THERAPY (NCT + ADJUVANT RT). Health Problems of Civilization. 2022;16(4):302-311. doi:10.5114/hpc.2022.121417.

APA

Maliarchuk, K., Ganul, A., Borisyuk, B., Bororov, L., Shevchenko, A.,  & Sovenko, V. et al. (2022). LIFE EXPECTANCY IN PATIENTS WITH STAGE III A NON-SMALL CELL LUNG CANCER (NSCLC) TREATED WITH NEOADJUVANT CHEMORADIOTHERAPY (NCRT), NEOADJUVANT CHEMOTHERAPY (NCT), NEOADJUVANT CHEMOTHERAPY + ADJUVANT RADIATION THERAPY (NCT + ADJUVANT RT). Health Problems of Civilization, 16(4), 302-311. https://doi.org/10.5114/hpc.2022.121417

Chicago

Maliarchuk, Katerina, Andrey Ganul, Bogdan Borisyuk, Leonid Bororov, Anatoly Shevchenko, Vladimir Sovenko,  and Lubov Kutsenko. 2022. "LIFE EXPECTANCY IN PATIENTS WITH STAGE III A NON-SMALL CELL LUNG CANCER (NSCLC) TREATED WITH NEOADJUVANT CHEMORADIOTHERAPY (NCRT), NEOADJUVANT CHEMOTHERAPY (NCT), NEOADJUVANT CHEMOTHERAPY + ADJUVANT RADIATION THERAPY (NCT + ADJUVANT RT)". Health Problems of Civilization 16 (4): 302-311. doi:10.5114/hpc.2022.121417.

Harvard

Maliarchuk, K., Ganul, A., Borisyuk, B., Bororov, L., Shevchenko, A., Sovenko, V.,  and Kutsenko, L. (2022). LIFE EXPECTANCY IN PATIENTS WITH STAGE III A NON-SMALL CELL LUNG CANCER (NSCLC) TREATED WITH NEOADJUVANT CHEMORADIOTHERAPY (NCRT), NEOADJUVANT CHEMOTHERAPY (NCT), NEOADJUVANT CHEMOTHERAPY + ADJUVANT RADIATION THERAPY (NCT + ADJUVANT RT). Health Problems of Civilization, 16(4), pp.302-311. https://doi.org/10.5114/hpc.2022.121417

MLA

Maliarchuk, Katerina et al. "LIFE EXPECTANCY IN PATIENTS WITH STAGE III A NON-SMALL CELL LUNG CANCER (NSCLC) TREATED WITH NEOADJUVANT CHEMORADIOTHERAPY (NCRT), NEOADJUVANT CHEMOTHERAPY (NCT), NEOADJUVANT CHEMOTHERAPY + ADJUVANT RADIATION THERAPY (NCT + ADJUVANT RT)." Health Problems of Civilization, vol. 16, no. 4, 2022, pp. 302-311. doi:10.5114/hpc.2022.121417.

Vancouver

Maliarchuk K, Ganul A, Borisyuk B, Bororov L, Shevchenko A, Sovenko V et al. LIFE EXPECTANCY IN PATIENTS WITH STAGE III A NON-SMALL CELL LUNG CANCER (NSCLC) TREATED WITH NEOADJUVANT CHEMORADIOTHERAPY (NCRT), NEOADJUVANT CHEMOTHERAPY (NCT), NEOADJUVANT CHEMOTHERAPY + ADJUVANT RADIATION THERAPY (NCT + ADJUVANT RT). Health Problems of Civilization. 2022;16(4):302-311. doi:10.5114/hpc.2022.121417.

Metryki PlumX:

Copyright: © 2022 Pope John Paul II State School of Higher Education in Biała Podlaska. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

PRZEWIDYWANA DŁUGOŚĆ ŻYCIA U PACJENTÓW Z NIEDROBNOKOMÓRKOWYM RAKIEM PŁUCA W STADIUM III A (NSCLC) PODDANYCH NEOADJUWANTOWEJ CHEMIORADIOTERAPII (NCRT), NEOADJUWANTOWEJ CHEMIOTERAPII (NCT), NEOADJUWANTOWEJ CHEMIOTERAPII + ADJUWANTOWEJ RADIOTERAPII (NCT + ADJUWANTOWA RT)

Katerina Maliarchuk 1 , Andrey Ganul 2 , Bogdan Borisyuk 2 , Leonid Bororov 2 , Anatoly Shevchenko 2 , Vladimir Sovenko 2 , Lubov Kutsenko 3

Katerina Maliarchuk

¹

,

Andrey Ganul

²

,

Bogdan Borisyuk

²

,

Leonid Bororov

²

,

Anatoly Shevchenko

²

,

Vladimir Sovenko

²

,

Lubov Kutsenko

³